Abbreviations
=============

V-ATPase

:   vacuolar ATPase

MVBs

:   multivesicular bodies

V1G1

:   subunit G1 of the V-ATPase

EEs

:   early endosomes

LEs

:   late endosomes

RILP

:   Rab-Interacting Lysosomal Protein

RAVE

:   Regulator of the ATPase of Vacuolar and Endosomal membranes

EGF

:   Epidermal Growth Factor
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The luminal pH of endocytic organelles and lysosomes is acidic; acidification increases progressively from endocytic vesicles and early endosomes (EEs) to late endosomes (LEs) and lysosomes. Each organelle maintains a specific internal pH, which is fundamental for its function.[@cit0001] Whereas the pH of EEs is in the 6.8--6.1 range, the pH of LEs is around 5.5 and it reaches values of 4.5--4.7 in lysosomes, these organelles being significantly acidic ([**Fig. 1**](#f0001){ref-type="fig"}). The acidic pH of endocytic organelles not only provides the environment for the activation of the degradative enzymes, but it is also essential for: 1) membrane trafficking, 2) for sorting endosomes to promote the uncoupling of internalized ligand--receptor complexes following receptor-mediated endocytosis, or 3) for the inactivation of internalized pathogens.[@cit0003] In addition acidification in EEs of mammalian cells is required for the formation of endosomal carrier vesicles or MVBs.[@cit0004] Importantly, dysregulation of organelle\'s acidification is associated to a variety of human diseases, such as osteoporosis, osteopetrosis, male infertility, renal acidosis, and cancer.[@cit0003] Several channels, transporters, and exchangers control pH of endo-lysosomes. Acidification involves a fine balance between H^+^ influx and efflux pathways, as well as counter-ion (anion and cation) conductance.[@cit0001] The action of the proton pumps, known as the vacuolar (V)-ATPases, using free energy of ATP hydrolysis, promotes the transport of the H^+^ into organelles lumen generating a voltage difference across the membrane.[@cit0001]^,^[@cit0009] Members of the ClC channel family, through the exchange of 2Cl^−^/H^+^, modulate luminal acidification providing anions that neutralize the gradual increase of positive charge in the lumen that inhibits V-ATPase activity.[@cit0001] In addition cation-conductive pathways (for example K^+^ channels) might also dissipate the voltage generated by the V-ATPase.[@cit0001]The functional interaction between the G1 subunit of the V-ATPase proton pump and RILP ([R]{.ul}ab-[I]{.ul}nteracting [L]{.ul}ysosomal [P]{.ul}rotein), a factor involved in endocytosis, has recently been investigated.[@cit0013] In this review we will discuss the molecular mechanism involved in this interaction and we will highlight the implications of this interaction in controlling V-ATPase activity and thus endosomes and lysosomes acidification. Figure 1.A model for the role of RILP in the recruitment of the V1 domain onto late endosome and lysosomes. The pH along the endocytic pathway gradually decreases from endosomes to lysosomes. The recruitment of RILP on endosomes and lysosomes, mediated by GTP-bound Rab7, promotes the subsequent recruitment of the V1 domain inducing reassembly of the V-ATPase, through the interaction of RILP with the V1G1 subunit. Depletion of RILP prevents the recruitment of V1G1 on late endosomal and lysosomal membranes promoting mislocalization of the V1G1 subunit (and possibly of the V1 domain) on Golgi membranes and affecting organelle\'s pH.

The V-ATPase proton pump {#s0002}
------------------------

V-ATPases are large multisubunit complexes organized into 2 domains composed of 14 different subunits that are organized into an ATP-hydrolytic domain (V1) and a proton-translocation domain (V0) that work together as a rotary machine.[@cit0003] The V1 domain is peripheral and is composed of 8 different subunits (A, B, C, D, E, F, G, and H) that hydrolyze ATP. The membrane V0 domain, composed of 6 subunits (a, c, c', c," d, and e), promotes the translocation of protons from the cytoplasm to the lumen or the extracellular space.[@cit0003] Mammals present a rich diversity of V-ATPase subunit isoforms, expressed in a tissue-specific manner; for example, the G1 subunit isoform is expressed ubiquitously, whereas the G2 isoform localizes in neuronal synaptic vesicles.[@cit0015] In most cases, the role of these various isoforms is not known, but a unique combination of subunit isoforms are found in specific cellular membranes.[@cit0004] The activity of V-ATPases in vivo is regulated by several mechanisms including reversible dissociation of the V1 and V0 domains.[@cit0003] The E and G subunit of the V1 domain are organized in 3 EG heterodimers that form 3 peripheral stalks.[@cit0016] The stalks provide transient elastic energy during the rotary catalytic cycle and the physical link between the V1 and V0 domain of the pump. The G subunit can, indeed, interact with the a subunit of the V0 domain.[@cit0017] In yeast, dissociation and assembly are independently controlled processes.[@cit0004] The reassembly requires a protein complex called RAVE ([r]{.ul}egulator of the [A]{.ul}TPase of [v]{.ul}acuolar and [e]{.ul}ndosomal membranes), composed of rav1, rav2, and of skp1, a component of ubiquitin ligase complexes.[@cit0004] RAVE interacts with dissociated V1 domains by binding with subunits E and/or G.[@cit0023]

Functional interaction between RILP and V1G1 {#s0003}
--------------------------------------------

Recently, we have identified a new functional interaction between the G1 subunit of the V-ATPase V1 domain and the N-terminal domain of RILP.[@cit0013] RILP is a downstream effector of the small GTPase Rab7, a Rab protein that controls transport to endocytic degradative compartments.[@cit0024] Rab7, in its active GTP-bound form, recruits RILP on membrane.[@cit0026] RILP is required for biogenesis of MVBs and, together with Rab7, for transfer of cargo from EEs, LEs, and MVBs to lysosomes.[@cit0026]^,^[@cit0028] Our data indicate that RILP, when bound to Rab7, recruits V1G1 on endosomes and lysosomes as we demonstrated that RILP is able to bind simultaneously to V1G1 at its N-terminal half and to Rab7 at its C-terminal half.[@cit0013] The recruitment of V1G1 is important for V-ATPase assembly and function.[@cit0013] Interestingly, overexpression of RILP increases the colocalization of V1G1 with late endosomal and lysosomal markers whereas depletion of RILP delocalizes V1G1 from LEs and lysosomes to Golgi membranes ([**Fig. 1**](#f0001){ref-type="fig"}).[@cit0013] As RILP-recruited V1G1 is also complexed with other V-ATPase subunits, binding of V1G1 to RILP seems to contribute to the correct assembly of the entire pump on lysosomal and endosomal membranes.[@cit0013] Indeed, RILP depletion causes not only V1G1 mislocalization, but also a different intracellular distribution of LysoTracker Red (a marker of acidic compartments), suggesting alterations in V-ATPase activity.[@cit0013] In addition, RILP depletion strongly delays degradation of the EGF receptor and affects MVBs formation again suggesting V-ATPase impairment.[@cit0029] Taken together, these data indicate that RILP, binding to V1G1, recruits the V-ATPase proton pump on late endosomal and lysosomal membranes promoting endosomal acidification and maturation. The correct amount of the V1G1 subunit is fundamental for V-ATPase activity.[@cit0031] Alterations in V1G1 expression destabilize the E subunit modulating V-ATPase assembly and affect cathepsin D maturation similarly to what happens in cells treated with the vacuolar pump inhibitor BafilomycinA1.[@cit0013] Moreover, V1G1 depletion causes accumulation of transferrin in acidic compartments suggesting alteration of trafficking at the endosomal level.[@cit0013] RILP strictly controls also V1G1 abundance, possibly in order to avoid V-ATPase proton pump activation on other organelles. Indeed, when RILP is not recruited on endosomes and lysosomes, as in the case of Rab7 silencing or of RILP overexpression, it induces ubiquitination-dependent proteasomal degradation of V1G1.[@cit0013] The proteasomal degradation of V1G1 could prevent mislocalization of V1G1 and thus altered activity of the proton pump on other compartments. Rab7T22N, a Rab7 mutant unable to recruit RILP to late endosomal/lysosomal membranes, causes a strong decrease in LysoTracker Red staining probably associated to an increase of pH of intracellular organelles.[@cit0026] In cells expressing Rab7T22N mutant, RILP binds V1G1 but can\'t recruit it on late endosomal and lysosomal membranes, probably affecting V-ATPase assembly and function on these organelles. At the same time, RILP could promote V1G1 degradation possibly preventing an increase of acidification in other organelles as observed in RILP-depleted cells.[@cit0013] The progressively acidification of endocytic organelles has a central role in endosomes maturation. Acidification, triggered by V-ATPase, in EEs of mammalian cells is required for the formation MVBs.[@cit0004] Defects of vesicular acidification block transport from early to LEs.[@cit0006] Different mechanisms control V-ATPase activity: 1) selection of V-ATPase isoforms and V-ATPase concentration on the membrane, 2) chemiosmotic mechanism modulated by the Cl^−^/H^+^ and Na^+^/H^+^ exchange mediated by channels and transporters, 3) changes in the efficiency of coupling proton transport, and 4) control of reversible dissociation and reassembly of the pump.[@cit0003] Our work discovered a new molecular mechanism involved in the control of V-ATPase reassembly at the level of endosomes and lysosomes in mammalian cells. The discovery of the functional interaction between RILP and V1G1 opens a new scenario on the regulation of the V-ATPase. RILP and Rab7, regulating V1G1 and thus V-ATPase assembly and activity at the endosomal level, may trigger downstream pathways giving rise to MVBs formation and endosomal progression. Thus, modulation of Rab7 and RILP could help to regulate V-ATPase assembly and activity, with important implications for the development of therapies against genetic and acquired diseases caused by V-ATPase alterations.
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